Welcome Guest
Sign In
Register
Home
Analytical Testing
Clinical Trials
Contract Research
Logistics
Manufacturing
Articles
Facility Tours
News
Events
Videos
Clinical Trials Documentary
A Solid Dosage Future Documentary
Whitepapers/App Notes
Issue Archives
Company Focus
Service Directory
Register
Sign In
Home
Product and Service Directory
Clinical Trial Development Services and Outsourcing
Contract Research Organizations / Contract Research Services (CRO Services)
Preclinical Contract Research / Preclinical Research Services (Preclinical CRO)
Preclinical Pharmacology Services
Preclinical Pharmacology Services
Preclinical Pharmacology Services
Preclinical Drug Efficacy Testing and Modeling Services
Preclinical Pharmaceutical Screening Services
Preclinical Pharmacology Services by Therapy Type
Preclinical Cancer Pharmacology / Oncology Pharmacology Services
Preclinical Cardiovascular Pharmacology Services
Preclinical Diabetes Pharmacology Services
Preclinical Inflammation Pharmacology Services
Preclinical Multiple Sclerosis Pharmacology Services
News
Cambrex Breaks Ground on $120M Charles City Expansion
Thursday, November 05, 2026
Cambrex has broken ground on a $120 million expansion at its Charles City, Iowa facility. The project will add 160,000 liters of manufacturing capacity, increasing the site's total capacity by approximately 25% to nearly one million liters.
read more
Alcami Promotes Robert Tragas to VP, Laboratory Services
Thursday, November 05, 2026
Alcami has promoted Robert Tragas to Vice President, Laboratory Services. In his expanded role, Tragas will lead laboratory operations across the CDMO's Research Triangle Park campus, overseeing analytical, biologics, microbiology and environmental monitoring functions.
read more
Samsung Biologics Earns 'Negligible Risk' ESG Rating
Thursday, November 05, 2026
Samsung Biologics has achieved a 'Negligible Risk' rating in the latest Morningstar Sustainalytics ESG Risk Ratings assessment. The CDMO received an ESG Risk Rating score of 9.0, advancing from its previous 'Low Risk' rating to 'Negligible Risk,' the lowest of five risk categories.
read more
Pyramid Pharma Services Adds 13th Commercial Product
Thursday, November 05, 2026
Pyramid Pharma Services has expanded a partnership with a longstanding biopharmaceutical customer to manufacture its 13th commercial product: a cartridge-based presentation of a therapy approved to treat rare blood cancers.
read more
Support your ADC program progression with expert insight
Wednesday, November 04, 2026
ADCs are transforming cancer therapy but manufacturing them is complex. Pfizer CentreOne's experts share actionable insights to help accelerate your program. Download the whitepaper today.
read more
More News
Featured Videos
A Solid Dosage Future
In the pharmaceutical manufacturing space, while biopharmaceuticals often dominate discussions, it's crucial to acknowledge the enduring significance of solid dosage products (e.g., tablets, capsules, pills). These traditional forms remain the ...
Pharma Flash - Biopharm Facility News and Regulatory Updates in this Week’s ...
Check out the top pharma news of the week from our Editor-In-Chief, Mike Auerbach. Watch video: Eli Lilly Chooses Vendor for Single-Use Facility and FDA Approves OTC oral contraceptive plus more news in this week’s Pharma Flash
More Videos
Featured Products and Services
We're sorry, no matching articles were found. Please select different filter options and try your search again.
More Featured Products
Featured Articles
We're sorry, no matching articles were found. Please select different filter options and try your search again.
Subscriptions
Get started here for your complimentary print or digital subscription
Sign up Now »